A simplified radiographic score effectively predicts radiographic progression of early arthritis in a large nationwide French cohort.

OBJECTIVE Evaluating radiographic progression is a key component of the follow-up of patients with RA. Existing scores are ill-suited to everyday clinical practice. The objective here was to validate a new simplified radiographic score (SRS) for evaluating radiographic progression in patients with early arthritis. METHODS Patients with arthritis of <6 months' duration were included in the large, prospective, nationwide, French ESPOIR cohort. Radiographs of the hands and feet were obtained at inclusion then 1 and 5 years later. The modified Sharp scores and SRS were determined by blinded readers. Interobserver reliability and intraobserver repeatability of each score, as well as agreement between the two scores, were assessed by computing the intraclass correlation coefficients. The rates of progression over the first year and the next 4 years were determined. RESULTS The 506 patients with complete data for the first 5 years were included. At inclusion, the intraclass correlation coefficient between the two scores was good for erosions (0.715, P < 0.001), joint space narrowing (0.892, P < 0.001) and the total score (0.896, P < 0.001). Agreement between the two scores was also good for radiographic progression after 1 year (0.781, P < 0.001). The SRS had good positive and negative predictive values for slow and for rapid progression. SRS determination was less time consuming. CONCLUSION The SRS is effective for monitoring radiographic progression in early arthritis and is easier to use and less time-consuming than the Sharp score. The usefulness of the SRS in clinical practice deserves further evaluation.

[1]  H. Brunner,et al.  THU0547 Real-world effectiveness of early aggressive treatment with biological disease-modifying antirheumatic drugs for the treatment of newly diagnosed polyarticular form of juvenile idiopathic arthritis , 2018, THURSDAY, 14 JUNE 2018.

[2]  W. Dixon,et al.  2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis , 2018, Annals of the rheumatic diseases.

[3]  J. Jacobs,et al.  Radiographic joint damage in early rheumatoid arthritis patients: comparing tocilizumab- and methotrexate-based treat-to-target strategies , 2018, Rheumatology.

[4]  W. Dixon,et al.  2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis , 2018, Annals of the rheumatic diseases.

[5]  M. Dougados,et al.  Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis , 2016, RMD Open.

[6]  M. Dougados,et al.  Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis. , 2014, Joint, bone, spine : revue du rhumatisme.

[7]  Helena Canhão,et al.  FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries , 2014 .

[8]  X. Mariette,et al.  First‐Year Radiographic Progression as a Predictor of Further Progression in Early Arthritis: Results of a Large National French Cohort , 2013, Arthritis care & research.

[9]  Désirée van der Heijde,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update , 2013, Annals of the rheumatic diseases.

[10]  J. Smolen,et al.  Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints. , 2011, Arthritis and rheumatism.

[11]  B. Dijkmans,et al.  A comparison between the simplified erosion and narrowing score and the Sharp–van der Heijde score: post hoc analysis from the BeSt study , 2010, Annals of the rheumatic diseases.

[12]  John Wong,et al.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs , 2010, Annals of the rheumatic diseases.

[13]  T. Pincus,et al.  Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations. , 2009, Rheumatic diseases clinics of North America.

[14]  L. Klareskog,et al.  Rheumatoid arthritis , 2009, The Lancet.

[15]  D. M. van der Heijde,et al.  Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade , 2008, Annals of the rheumatic diseases.

[16]  M. Dougados,et al.  The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. , 2007, Joint, bone, spine : revue du rhumatisme.

[17]  I. Boutron,et al.  Reporting of radiographic methods in randomised controlled trials assessing structural outcomes in rheumatoid arthritis , 2006, Annals of the Rheumatic Diseases.

[18]  F. Guillemin,et al.  Prevalence of rheumatoid arthritis in France: 2001 , 2005, Annals of the rheumatic diseases.

[19]  Désirée van der Heijde,et al.  The Sharp/van der Heijde method out-performed the Larsen/Scott method on the individual patient level in assessing radiographs in early rheumatoid arthritis. , 2004, Journal of clinical epidemiology.

[20]  F Guillemin,et al.  Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. , 2001, Annals of the rheumatic diseases.

[21]  D. M. van der Heijde,et al.  The course of radiologic damage during the first six years of rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[22]  D. M. van der Heijde,et al.  Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. , 1999, Rheumatology.

[23]  Désirée van der Heijde,et al.  Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. , 1996 .

[24]  A. Larsen,et al.  How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. , 1995, The Journal of rheumatology.

[25]  C. Metz.  Basic principles of ROC analysis. , 1978, Seminars in nuclear medicine.

[26]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.

[27]  O. Steinbrocker,et al.  Therapeutic criteria in rheumatoid arthritis. , 1949, Journal of the American Medical Association.

[28]  B. Combe,et al.  Early lessons from the recent-onset rheumatoid arthritis cohort ESPOIR. , 2015, Joint, bone, spine : revue du rhumatisme.

[29]  M. Dougados,et al.  The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound , 2012, Annals of the rheumatic diseases.

[30]  A. Silman,et al.  UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .

[31]  M. V. van Leeuwen,et al.  Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). , 1995, The Journal of rheumatology.